DailyDoctor Archive Specialties Get app
Back to the 21 October 2026 edition

Research · 04 of 06

Augmentation cystoplasty after spinal cord injury: durable at 19 years, with stones and cancer to watch for

Augmentation cystoplasty gives durable results in refractory neurogenic bladder after spinal cord injury, but commits the patient to lifelong surveillance.

Design
Single-centre retrospective cohort
Population
70 people with spinal cord injury and refractory neurogenic bladder, mean follow-up 19 years
Primary outcome
Urodynamic, continence and complication outcomes
Effect
Capacity 155 to 490 mL; pressure 72 to 19 cmH₂O; 67% continent; adenocarcinoma 4%

A tertiary centre reviewed 70 people with spinal cord injury and refractory neurogenic bladder dysfunction who had augmentation cystoplasty between 1988 and 2018, with a mean follow-up of 19 years.

Bladder capacity rose from a mean of 155 to 490 mL and maximum detrusor pressure fell from 72 to 19 cmH₂O. Two-thirds were fully continent and a further 24% had only occasional leakage. Recurrent infections and antimuscarinic use fell, and reflux improved in most. Late complications included stones in 10%, adenocarcinoma in 4% and spontaneous perforation in 1.5%. Eighteen patients needed adjunctive intradetrusor botulinum toxin, with further improvement in selected measures.

This is a single-centre retrospective series, and those who were lost or died may have fared differently.

The operation still has a place where less invasive options have failed, provided patients understand that surveillance is lifelong.

  • Consider augmentation cystoplasty for refractory neurogenic bladder after spinal cord injury when less invasive options fail.
  • Counsel about a lifelong risk of stones, perforation and adenocarcinoma in the augmented bladder.
  • Arrange structured lifelong surveillance after augmentation.
  • Consider intradetrusor botulinum toxin if pressures rise again after augmentation.

Why it matters

Long follow-up is what patients considering a major reconstruction need, and it is rarely available.

The statistics, in plain English

A 4% cancer rate over 19 years in 70 patients is about three people, so the estimate is imprecise, but it confirms a real long-term risk.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

prostatecanceruroutikidneycancer

Tomorrow morning, before your first patient

One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app